Dr. Lal PathLabs Limited
LALPATHLAB
Pozycja w akcjach
#4509
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health... Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
Cena akcji
$20.35
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$3.40B
Zmiana (1 dzień)
-0.86%
Zmiana (1 rok)
13.63%
Kraj
IN
Handel Dr. Lal PathLabs Limited (LALPATHLAB)
Kategoria
Healthcare
Zyski dla Dr. Lal PathLabs Limited (LALPATHLAB)
Zyski w Jun 2026 TTM: $79.09M
Według najnowszych raportów finansowych Dr. Lal PathLabs Limited, obecny zysk firmy wynosi $79.09M. W roku 2024 firma osiągnęła zysk w wysokości $60.62M, wzrost w porównaniu do zysku z roku 2023, który wynosił $41.84M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Dr. Lal PathLabs Limited od 2011 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $79.09M | 8.27% |
| 2025 | $73.05M | 20.51% |
| 2024 | $60.62M | 44.89% |
| 2023 | $41.84M | -33.14% |
| 2022 | $62.57M | 16.14% |
| 2021 | $53.88M | 30.72% |
| 2020 | $41.22M | -4.77% |
| 2019 | $43.28M | 7.84% |
| 2018 | $40.13M | 9.90% |
| 2017 | $36.52M | 20.54% |
| 2016 | $30.30M | 35.31% |
| 2015 | $22.39M | -3.94% |
| 2014 | $23.31M | 57.92% |
| 2013 | $14.76M | 12.68% |
| 2012 | $13.10M | 30.51% |
| 2011 | $10.04M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| $7.61B | 9,520.18% |
US
|
|
| $4.76B | 5,920.67% |
US
|
|
| $-252.70M | -419.49% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 1,996.24% |
US
|
